Trade of the Week: Zoom

Trade of the Week: Zoom

There was 3.5x the normal volume of options in Zoom Video Communications (ZM) on one day last week. 64% of the trade were calls, which suggests a slightly bullish bias. ZM had dropped quite a bit recently after releasing disappointing earnings. However, Cathie Wood and her ARKK fund decided to use the opportunity to buy more ZM shares. This […]

Symbol of FED federal reserve of USA. 3d illustration

What The Fed Is Really Doing With OUR Money

The Federal Reserve is owned by “Member Banks” that have now merged into huge brokerage, investment firms; many deemed “Too big to be allowed to fail”. G. Edward Griffin explains: “The Federal Reserve is a cartel- it’s a banking cartel. And like all cartels, it only has one purpose – and that is to serve […]

Stock market chart

Three Fundamental Investment Tools to Always Consider

When you buy a stock, it’s often a good idea to understand exactly what you’re paying for. More specifically, you want to know whether you’ve found a bargain or are paying too much. We can determine this using fundamental tools, such as the price-to-earnings (P/E) ratio, the price-to-earnings growth (PEG) ratio, and the price-to-sales (P/S) […]

Taking Profits on This Stock I Called in July

Taking Profits on This Stock I Called in July

In July, I recommended a tech stock buy. The stock has run up some and I’m actually taking profits as it’s popped 10% in two months. Watch my short video: 1. To see the trade I called and made But, maybe more importantly… 2. Learn how I approach a trade to know when to take […]

DIVIDENDS CONCEPT

Three Top Monthly Dividend Stocks Investors Should Consider

Most dividend-paying stocks will dole out payments quarterly, or at least semi-annually. However, some will pay out dividends monthly, making those stocks far more attractive to investors. Take a look at Realty Income (O), for example. The retail REIT’s monthly payments are supported by cash flow from more than 6,700 real estate properties owned “under […]

Agenus is a Speculative Trade Worth the Risk

Agenus is a Speculative Trade Worth the Risk

Angenus (AGEN) is a biotech company focused on clinical-stage immuno-oncology, with 17 candidates in development. Nine of those candidates are company owned, while the rest are with partnerships of some well-known drug makers. AGEN also has three experimental vaccines in clinical studies, as well as two adjuvants, which are substances that enhance the body’s immune […]